Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease

Blood Purification

Volumn 26, Issue 6, 2008, Pages 518-525

  Lindblad, Ylva Tranæus ^a   Axelsson, Jonas ^a   Bárány, Peter ^a   Celsi, Gianni ^a   Lindholm, Bengt ^a   Qureshi, Abdul Rashid ^a   Carrea, Alba ^b   Canepa, Alberto ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Body mass index; C reactive protein; Cardiovascular disease; Glomerular filtration rate; Hyperinsulinemia; Inflammation; Malnutrition

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MALNUTRITION; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; GLOMERULAR FILTRATION RATE; HUMANS; HYPERINSULINISM; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALNUTRITION; RISK FACTORS;

EID: 55149122913     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167799     Document Type: Article

References (44)

1. The US Renal Data System: USRDS 1998 Annual Report. Causes of death. Am J Kidney Dis 1998;32:S81-S88.
2. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996;32:112-119.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
4. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary artery calcifications in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
5. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood onset renal failure. Circulation 2002;106:100-102.
6. Gruppen MP, Groothoff JW, Prins M, van der Wouw P, Offringa M, Bos WJ, Davin JC, Heymans HS: Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 2003;63:1058-1065.
7. Parekh RS, Carroll CE, Wolfe RA, Port FK: Cardiovascular mortality in children and young adults with end stage renal disease. J Pediatr 2002;141:191-197.
8. Matteucci MC, Wühl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, Simone G, Schaefer F; ESCAPE Trial Group: Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006;17:218-226.
9. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Schaefer F: Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005;16:1494-1500.
10. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098.
11. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S: Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002;51:1226-1232.
12. Chen J, Muntner P, Hamm LL, Fonseca V, Bautman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-477.
13. Alvestrand A: Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997;52:48-52.
14. Lai HL, Kartal J, Mitsnefes M: Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-alpha. Pediatr Nephrol 2007;22:1751-1756.
15. Mak RH: Insulin secretion and growth failure in uremia. Pediatr Res 1995;38:378-383.
16. Parra A, Lopez-Uriarte A, Argote RM, Garcia G, Ledón S, Santos D: Effect of hemodialysis on glucose tolerance in children with chronic renal failure. Arch Invest Med 1979;10:39-52.
17. Buyan N, Bideci A, Ozkaya O, Ortac E, Bakkaloglu S, Gonen S, Peru H, Soylemezoglu O, Cinaz P: Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis. Nephrology 2006;11:192-196.
18. Shishido S, Sato H, Asanuma H, Shindo M, Hataya H, Ishikura K, Hamasaki Y, Goto M, Ikeda M, Honda M: Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant 2006;10:1-4.
19. Haffner D, Nissel R, Wühl E, Schaefer F, Bettendorf M, Tönshoff B, Mehls O: Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Res 1998;43:209-215.
20. McCaleb ML, Izzo MS, Lockwood DH: Characterization and partial purification of a factor from uremic serum that induces insulin resistance. J Clin Invest 1985;75:391-396.
21. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA: Insulin resistance is associated with skeletal muscle breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007;71:146-152.
22. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596-604.
23. Stenvinkel P, Alvestrand A: Inflammation in end stage renal disease: sources, consequences and therapy. Semin Dial 2002;15:329-337.
24. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
25. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P: Interleukin 6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transpl 2002;17:1684-1688.
26. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL: Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002;105:650-655.
27. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
28. Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO: Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 2002;61:630-637.
29. Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C: Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 2000;36:811-819.
30. Foster BJ, Leonard MB: Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr 2004;80:801-814.
31. Mehrotra R: Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease. Kidney Int 2007;72:137-140.
32. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU: 2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.
33. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S: Serum fetuin-A in non-dialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 2005;67:1070-1077.
34. Wu DM, Chu NF, Shen MH, Wang SC: Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem 2006;39:810-815.
35. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-590.
36. Moran A, Jacobs D, Steinberger J, Hong CH, Prineas R, Luepker R, Sinaiko A: Insulin resistance during puberty. Results from clamp studies in 357 children. Diabetes 1999;48:2039-2044.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
38. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C: Homeostasis model assessments is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin among obese children and adolescents. Pediatrics 2005;115:500-503.
39. Ronnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, Kaprio EA, Salo MK, Dahl M, Nuutinen EM: Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 1991;23:67-72.
40. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
41. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:1894-1900.
42. Fadini GP, Pauletto P, Avogaro A, Rattazzi M: The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis 2007;193:241-244.
43. Liu Z: The renin-angiotensin system and insulin resistance. Curr Diab Rep 2007;7:34-42.
44. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transpl 2004;19:150-157.